Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Non-Invasive Electroceuticals Offer Drug-Free Pain Relief

By HospiMedica International staff writers
Posted on 16 Nov 2020
A pulsed shortwave therapy (PSWT) device treats any form of musculoskeletal pain, increases physical functionality, and improves overall quality of life.

The BioElectronics (Frederick, MD, USA) ActiPatch treats various types of pain via diathermal electromagnetic energy delivered by repeated application of a PSWT signal at intensity levels too low to trigger a pain response. The signal can, however, still initiate a neural system response, as it is not only exposed to the applied signal, but also to background physiologic signals, which enhances the detection of sub-threshold stimuli. The PSWT signal is delivered at a frequency of 27.12 MHz and pulses of 1,000 times per second, which each pulse sustained for a duration of 100 μs.

The prolonged stochastic stimuli, which the brain cannot really interpret, are sufficiently large to exceed the threshold necessary to activate nerves. Since sensory nerves have a lower threshold of activation as compared to motor nerves and muscles, the low incident power is sufficient to non-deterministically modulate their activity. And as the signal is lower than the stochastic resonance threshold, the patient experiences no heat, nor any other abnormal or unpleasant sensation. The PSWT localized treatment can be used as either a standalone or adjunct therapy, depending on the condition being treated.

“Electroceutical devices can target central sensitization and are ideal for treating pain, but existing options, such as transcutaneous electrical nerve stimulation, require invasive or semi-invasive use and produce uncomfortable sensations,” said the company in a press statement. “ActiPatch reduces chronic pain by mitigating nerve hypersensitivity associated with central sensitization. This means that our products can be further developed to treat disorders beyond pain such as overactive bladder.”

ActiPatch is available in three forms: a back wrap, a knee wrap, and as an adhesive which can be applied as per specifications at the site of chronic, persistent pain, such as for back pain, knee/shoulder/ankle arthritis, postoperatively after knee/spine surgeries, tendonitis, ligament injury, elbow/wrist persistent pain, plantar fasciitis, and fibromyalgia. It contains an electronics module and a wire loop that is placed around the affected area. Total usage duration is 720 hours.

Related Links:
BioElectronics


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Aortic Valve Replacement System
INTUITY Elite
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The diffusion model was trained on real LGE-MRI distributions and generated synthetic fibrosis distributions from Gaussian noise (Photo courtesy of Frontiers, DOI: 10.3389/fcvm.2025.1512356)

AI-Generated Synthetic Scarred Hearts Aid Atrial Fibrillation Treatment

Atrial fibrillation (AF) is a common heart rhythm disorder, often linked to the development of fibrosis, which is the formation of scar tissue in the heart. This fibrosis typically arises due to aging,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.